|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: TX - Dallas |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: TX - El Paso |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: TX - Fort Worth |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: TX - Houston |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: TX - Lubbock |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: TX - Lufkin |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: TX - San Antonio |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: TX - Texas |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: TX - Waco |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: UT - Salt Lake City |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: UT - Utah |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: VA - Alexandria |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: VA - Arlington |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: VA - Norfolk |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: VA - Richmond |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: VA - Virginia |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: VA - Virginia Beach |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: VI - Virgin Islands |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: VT - Burlington |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: VT - Vermont |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: WA - Seattle |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: WA - Tacoma |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: WA - Washington |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: WI - Madison |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: WI - Milwaukee |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: WI - Wisconsin |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: WV - Charleston |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: WV - West Virginia |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: AL - Montgomery |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|
|
Over 6 million people in the US are affected by Heart Failure in the US with that number expected to increase to 8 million by 2030. Novartis has been at the forefront of cardiovascular treatment for decades, delivering groundbreaking medicines that extend and improve life, and that’s where we intend to stay there.
We are Novartis.
Join us and help reimagine medicine!
|
Company: Novartis |
Location: AL- Mobile |
Position: Pharmaceutical Sales |
Posted: 4/20/2025 |
|
|